SECsense Logo

Silexion Therapeutics Corp 8-K Report: Key Insights on Shares & Warrants

$SLXN
Form 8-K
Filed on: 2025-01-14
Source
Silexion Therapeutics Corp 8-K Report: Key Insights on Shares & Warrants

Based on the provided section of the financial report, here are the key insights extracted:

  1. Entity Identification:
  • Company Name: Silexion Therapeutics Corp
  • CIK: 0002022416
  • SEC Filing Type: Form 8-K
  • Filing Date: January 14, 2025
  1. Stock Information:
  • Ordinary Shares: The company has ordinary shares with a par value of $0.0009 per share.
  • Warrants: There are warrants exercisable for ordinary shares at an exercise price of $103.5 per share.
  1. Filing Context:
  • The report provides a specific context for two types of stock:
    • Warrants: The warrants are associated with ordinary shares at an exercise price of $11.50 per share.
    • Ordinary Shares: The ordinary shares also have a mention of a par value of $0.0001.
  1. Company Address:
  • Location: 12 Abba Hillel Road, Ramat-Gan, IL 5250606, Israel.
  1. Market Information:
  • The company is listed on the NASDAQ under the ticker symbols SLXN for ordinary shares and SLXNW for the warrants.
  1. Regulatory Information:
  • The filing is associated with the XBRL (eXtensible Business Reporting Language) format, which is used for financial reporting to the SEC.

Summary

Silexion Therapeutics Corp filed an 8-K report on January 14, 2025, detailing its ordinary shares and warrants. The ordinary shares have a par value of $0.0009, while the warrants can be exercised at $103.5 per share. The report adheres to regulatory standards and utilizes XBRL for data representation. The company is located in Israel and is publicly traded on NASDAQ.